SE392902B - Forfarande for framstellning av fenylimidazolidinoner - Google Patents

Forfarande for framstellning av fenylimidazolidinoner

Info

Publication number
SE392902B
SE392902B SE7207420A SE742072A SE392902B SE 392902 B SE392902 B SE 392902B SE 7207420 A SE7207420 A SE 7207420A SE 742072 A SE742072 A SE 742072A SE 392902 B SE392902 B SE 392902B
Authority
SE
Sweden
Prior art keywords
phenylimidazolidinones
procedure
preparation
Prior art date
Application number
SE7207420A
Other languages
English (en)
Swedish (sv)
Inventor
A Mentrup
E-O Renth
K Schromm
P Danneberg
Original Assignee
Boehringer Sohn Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Sohn Ingelheim filed Critical Boehringer Sohn Ingelheim
Publication of SE392902B publication Critical patent/SE392902B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/32—One oxygen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SE7207420A 1971-06-07 1972-06-06 Forfarande for framstellning av fenylimidazolidinoner SE392902B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT492071A AT311956B (de) 1971-06-07 1971-06-07 Verfahren zur Herstellung neuer Phenylimidazolidinonderivate und ihrer Salze

Publications (1)

Publication Number Publication Date
SE392902B true SE392902B (sv) 1977-04-25

Family

ID=3569889

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7207420A SE392902B (sv) 1971-06-07 1972-06-06 Forfarande for framstellning av fenylimidazolidinoner

Country Status (20)

Country Link
AR (7) AR200112A1 (xx)
AT (1) AT311956B (xx)
AU (1) AU473287B2 (xx)
BE (1) BE784475A (xx)
BG (1) BG22822A3 (xx)
CA (1) CA1011336A (xx)
CH (7) CH591475A5 (xx)
DD (1) DD101403A5 (xx)
DE (1) DE2223751A1 (xx)
ES (1) ES403542A1 (xx)
FR (1) FR2140492B1 (xx)
GB (1) GB1391491A (xx)
HU (1) HU165493B (xx)
IE (1) IE37812B1 (xx)
IL (1) IL39620A (xx)
NL (1) NL7207701A (xx)
NO (1) NO136841C (xx)
SE (1) SE392902B (xx)
SU (8) SU493067A3 (xx)
ZA (1) ZA723840B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19822678A1 (de) * 1998-05-20 1999-11-25 Bayer Ag Substituierte 1,3-Diaza-2-(thi)oxo-cycloalkane
CA2568609A1 (en) * 2003-05-28 2004-12-09 Imotep Inc. Haloethyl urea compounds and their use to attenuate, inhibit or prevent non-cancerous pathogenic cellular proliferation and diseases associated therewith
WO2004106291A1 (en) * 2003-05-28 2004-12-09 Imotep Inc. Haloethyl urea compounds and the use thereof to attenuate, inhibit or prevent cancer cell migration
RU2497810C1 (ru) * 2012-06-28 2013-11-10 Общество с ограниченной ответственностью "Объединенный центр исследований и разработок" Способ получения n,n-диарилзамещенных 2-трихлорометилимидазолидинов

Also Published As

Publication number Publication date
CH583729A5 (xx) 1977-01-14
NL7207701A (xx) 1972-12-11
SU493067A3 (ru) 1975-11-25
DE2223751A1 (de) 1972-12-28
CH573425A5 (xx) 1976-03-15
AU4312972A (en) 1973-12-13
SU509228A3 (ru) 1976-03-30
AR200139A1 (es) 1974-10-24
AR205522A1 (es) 1976-05-14
BE784475A (fr) 1972-12-06
AU473287B2 (en) 1973-12-13
SU498907A3 (ru) 1976-01-05
SU453839A3 (ru) 1974-12-15
SU503516A3 (ru) 1976-02-15
ES403542A1 (es) 1975-05-01
SU492085A3 (ru) 1975-11-15
CH591475A5 (xx) 1977-09-15
AR202904A1 (es) 1975-07-31
IL39620A (en) 1977-02-28
AR200112A1 (es) 1974-10-24
GB1391491A (en) 1975-04-23
IL39620A0 (en) 1972-08-30
BG22822A3 (xx) 1977-04-20
AR203017A1 (es) 1975-08-08
IE37812L (en) 1972-12-07
FR2140492A1 (xx) 1973-01-19
ZA723840B (en) 1974-02-27
FR2140492B1 (xx) 1976-03-05
AR207109A1 (es) 1976-09-15
CH590269A5 (xx) 1977-07-29
CH589645A5 (xx) 1977-07-15
NO136841B (no) 1977-08-08
IE37812B1 (en) 1977-10-26
AT311956B (de) 1973-12-10
CA1011336A (en) 1977-05-31
CH589646A5 (xx) 1977-07-15
AR202903A1 (es) 1975-07-31
NO136841C (no) 1977-11-16
SU505358A3 (ru) 1976-02-28
SU499806A3 (ru) 1976-01-15
DD101403A5 (de) 1973-11-05
HU165493B (xx) 1974-09-28
CH589644A5 (xx) 1977-07-15

Similar Documents

Publication Publication Date Title
SE392269B (sv) Forfarande for framstellning av vissa indanyloxitetrazoler
SE398877B (sv) Forfarande for framstellning av 14-hydroxi-morfinanderivat
SE411755B (sv) Forfarande for framstellning av n-substituerade 1-aminometylindaner
SE400292B (sv) Forfarande for framstellning av benshydryl-3-karbamoyloximetyl-7-tienylacetamido-7-metoxidecefalosporanat
NO147916C (no) Fremgangsmaate for fremstilling av 3-metylen-cefalosporin-forbindelser.
SE390633B (sv) Forfarande for framstellning av ethambutol
SE417200B (sv) Forfarande for framstellning av 2-nitro-5-imidazolaldehydderivat
SE400764B (sv) Forfarande for framstellning av substituerade 3-hydroximetylisokinoliner
SE393615B (sv) Forfarande for framstellning av 6-metyl-8 beta-ureidometyl-ergolener
SE397090B (sv) Forfarande for framstellning av hydroxipyrimidiner
SE405478B (sv) Forfarande for framstellning av alfa-sulfoacylcefalosporiner
SE384686B (sv) Forfarande for framstellning av linkomycinderivat
SE391332B (sv) Forfarande for framstellning av en fenyletanolamin
SE412756B (sv) Alternativa forfarande for framstellning av 2-(aminofenylimino)-3-aza-1-tia-cykloalkaner
SE408177B (sv) Forfarande for framstellning av 4-hydroximetyl-1-ftalazonderivat
SE387936B (sv) Forfarande for framstellning av substituerade metoxiaminer
SE382985B (sv) Forfarande for framstellning av oxazoler
SE380520B (sv) Forfarande for framstellning av 1-cinnamylidenamino-3-bensylidenaminoguanidin
SE380815B (sv) Forfarande for framstellning av transparenta sampolyamider
SE398123B (sv) Forfarande for framstellning av metoximetylestern av hetacillin
SE392902B (sv) Forfarande for framstellning av fenylimidazolidinoner
SE386897B (sv) Forfarande for framstellning av n-acyl-(piperazinoetyl)-pyrazoler
SE405730B (sv) Forfarande for framstellning av kinazolinderivat
SE397350B (sv) Forfarande for framstellning av tieno-diazepinderivat
SE387948B (sv) Forfarande for framstellning av tiofen